[1]
|
Walusinski, O. (2020) Armand Trousseau (1801-1867), a Neurologist before Neurology. Revue Neurologique (Paris), 176, 531-542. https://doi.org/10.1016/j.neurol.2019.12.002
|
[2]
|
Sanon, S., Lenihan, D.J. and Mouhayar, E. (2011) Peripheral Arterial Ischemic Events in Cancer Patients. Vascular Medicine, 16, 119-130. https://doi.org/10.1177/1358863X10388346
|
[3]
|
Di Nisio, M., Ferrante, N., Feragalli, B., De Tursi, M., Iacobelli, S., Cuccurullo, F. and Porreca, E. (2011) Arterial Thrombosis in Ambulatory Cancer Patients Treated with Chemotherapy. Thrombosis Research, 127, 382-383.
https://doi.org/10.1016/j.thromres.2010.10.001
|
[4]
|
Kim, S.J., Park, J.H., Lee, M.J., Park, Y.G., Ahn, M.J. and Bang, O.Y. (2012) Clues to Occult Cancer in Patients with Ischemic Stroke. PLOS ONE, 7, e44959. https://doi.org/10.1371/journal.pone.0044959
|
[5]
|
Chen, W., He, Y. and Su, Y. (2018) Multifocal Cerebral Infarc-tion as the First Manifestation of Occult Malignancy: Case Series of Trousseau’s Syndrome and Literature Review. Brain Circulation, 4, 65.
https://doi.org/10.4103/bc.bc_1_18
|
[6]
|
Spyropoulos, A.C., Hussein, M., Lin, J. and Battleman, D. (2009) Rates of Venous Thromboembolism Occurrence in Medical Patients among the Insured Population. Thrombosis and Haemo-stasis, 102, 951-957.
https://doi.org/10.1160/TH09-02-0073
|
[7]
|
Kim, S.G., Hong, J.M., Kim, H.Y., Lee, J., Chung, P.W., Park, K.Y., Kim, G.M., Lee, K.H., Chung, C.S. and Bang, O.Y. (2010) Ischemic Stroke in Cancer Patients with and without Con-ventional Mechanisms: A Multicenter Study in Korea. Stroke, 41, 798-801. https://doi.org/10.1161/STROKEAHA.109.571356
|
[8]
|
Adess, M., Eisner, R., Nand, S., Godwin, J., Messmore Jr., H.L. and Wehrmacher, W.H. (2006) Thromboembolism in Cancer Patients: Pathogenesis and Treatment. Clinical and Applied Thrombosis/Hemostasis, 12, 254-266.
https://doi.org/10.1177/1076029606291432
|
[9]
|
Zhen, C., Wang, Y., Wang, H., Li, D. and Wang, X. (2021) Mul-tiple Cerebral Infarction Linked to Underlying Cancer: A Review of Trousseau Syndrome-Related Cerebral Infarction. British Journal of Hospital Medicine (London), 82, 1-7.
https://doi.org/10.12968/hmed.2020.0696
|
[10]
|
Nam, K.W., Kim, C.K., Kim, T.J., An, S.J., Oh, K., Mo, H., Kang, M.K., Han, M.K., Demchuk, A.M., Ko, S.B. and Yoon, B.W. (2017) Predictors of 30-Day Mortality and the Risk of Recurrent Systemic Thromboembolism in Cancer Patients Suffering Acute Ischemic Stroke, PLOS ONE, 12, e0172793. https://doi.org/10.1371/journal.pone.0172793
|
[11]
|
Ito, S., Kikuchi, K., Ueda, A., Nagao, R., Maeda, T., Murate, K., Shima, S., Mizutani, Y., Niimi, Y. and Mutoh, T. (2018) Changes in Serial D-Dimer Levels Predict the Prognoses of Trousseau’s Syndrome Patients. Frontiers in Neurology, 9, Article No. 528. https://doi.org/10.3389/fneur.2018.00528
|
[12]
|
Guo, Y.J., Chang, M.H., Chen, P.L., Lee, Y.S., Chang, Y.C. and Liao, Y.C. (2014) Predictive Value of Plasma (D)-Dimer Levels for Cancer-Related Stroke: A 3-Year Retrospective Study. Journal of Stroke and Cerebrovascular Diseases, 23, e249-e254. https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.10.022
|
[13]
|
Umemura, T., Yamamoto, J., Akiba, D. and Nishizawa, S. (2017) Bilateral Cerebral Embolism as a Characteristic Feature of Patients with Trousseau Syndrome. Journal of Clinical Neuroscience, 42, 155-159.
https://doi.org/10.1016/j.jocn.2017.04.014
|
[14]
|
Chu, H., Zhang, C., Shi, Y., Wu, W., Hu, Z., Zhang, J. and Huang, D. (2020) Gallbladder Neuroendocrine Carcinoma: A Single Center Experience. Medicine (Baltimore), 99, e21912. https://doi.org/10.1097/MD.0000000000021912
|
[15]
|
连峰. 原发性胆囊癌术后预后影响因素分析[D]: [硕士学位论文]. 长春: 吉林大学, 2020.
|
[16]
|
Wen, H.M., Lam, W.W., Rainer, T., Fan, Y.H., Leung, T.W., Chan, Y.L. and Wong, K.S. (2004) Multiple Acute Cerebral Infarcts on Diffusion-Weighted Imaging and Risk of Recurrent Stroke. Neurology, 63, 1317-1319.
https://doi.org/10.1212/01.WNL.0000140490.22251.B6
|
[17]
|
Ishikawa, M., Nakayama, K., Ishibashi, T., Sato, E., Nakamura, K., Katagiri, H. and Kyo, S. (2016) Case Series of Cerebral Infarction with Trousseau’s Syndrome Associat-ed with Malignant Gynecological Tumors. Molecular and Clinical Oncology, 5, 138-142. https://doi.org/10.3892/mco.2016.888
|
[18]
|
Masrur, S., Abdullah, A.R., Smith, E.E., Hidalgo, R., El-Ghandour, A., Rordorf, G. and Schwamm, L.H. (2011) Risk of Thrombolytic Therapy for Acute Ischemic Stroke in Patients with Cur-rent Malignancy. Journal of Stroke and Cerebrovascular Diseases, 20, 124-130. https://doi.org/10.1016/j.jstrokecerebrovasdis.2009.10.010
|
[19]
|
Murthy, S.B., Karanth, S., Shah, S., Shastri, A., Rao, C.P., Bershad, E.M. and Suarez, J.I. (2013) Thrombolysis for Acute Ischemic Stroke in Patients with Cancer: A Population Study. Stroke, 44, 3573-3576.
https://doi.org/10.1161/STROKEAHA.113.003058
|